THYMIDYLATE SYNTHASE GENE AMPLIFICATION IN HUMAN COLON-CANCER CELL-LINES RESISTANT TO 5-FLUOROURACIL

被引:175
作者
COPUR, S
AIBA, K
DRAKE, JC
ALLEGRA, CJ
CHU, E
机构
[1] NCI,NAVY MED ONCOL BRANCH,BETHESDA,MD 20889
[2] JAPANESE FDN CANC RES,CTR CANC CHEMO,TOKYO,JAPAN
关键词
THYMIDYLATE SYNTHASE; GENE AMPLIFICATION; 5-FU RESISTANCE;
D O I
10.1016/0006-2952(95)00067-A
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A series of 5-fluorouracil (5-FU)-resistant human colon H630 cancer cell lines were established by continuous exposure of cells to 5-FU. The concentration of 5-FU required to inhibit cell proliferation by 50% (IC50) in the parent colon line (H630) was 5.5 mu M. The 5-FU IC50 values for the resistant H630-R1, H630-R10, and H630-R cell lines were 11-, 29-, and 27-fold higher than that for the parent H630 cell line. Using both the radioenzymatic 5-fluoro-2'-deoxyuridine-5'-monophosphate (FdUMP) binding and catalytic assays for measurement of thymidylate synthase (TS) enzyme activity, there was significantly increased TS activity in resistant H630-R1 (13- and 23-fold), H630-R10 (37- and 40-fold), and H630-R (24- and 34-fold) lines, for binding and catalytic assays, respectively, compared with the parent H630 line. The level of TS protein, as determined by western immunoblot analysis, was increased markedly in resistant H630-R1 (23-fold), H630-R10 (33-fold), and H630-R (26-fold) cells. Northern analysis revealed elevations in TS mRNA levels in H630-R1 (18-fold), H630-R10 (39-fold), and H630-R (36-fold) cells relative to parent H630 cells. Although no major rearrangements of the TS gene were noted by Southern analysis, there was significant amplification of the TS gene in 5-FU-resistant cells, which was confirmed by DNA slot blot analysis. These studies demonstrate that continuous exposure of human colon cancer cells to 5-FU leads to TS gene amplification and overexpression of TS protein with resultant development of fluoropyrimidine resistance.
引用
收藏
页码:1419 / 1426
页数:8
相关论文
共 44 条
[1]  
ARDALAN B, 1980, CANCER RES, V40, P1431
[2]  
ASCHELE C, 1992, CANCER RES, V52, P1855
[3]  
BERGER SH, 1988, MOL PHARMACOL, V34, P480
[4]  
BERGER SH, 1985, MOL PHARMACOL, V28, P461
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   ENHANCEMENT OF METHOTREXATE RESISTANCE AND DIHYDROFOLATE-REDUCTASE GENE AMPLIFICATION BY TREATMENT OF MOUSE 3T6-CELLS WITH HYDROXYUREA [J].
BROWN, PC ;
TLSTY, TD ;
SCHIMKE, RT .
MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (06) :1097-1107
[7]  
CANMAN CE, 1994, CANCER RES, V54, P2296
[8]   VARIATIONS IN PATTERNS OF DNA DAMAGE INDUCED IN HUMAN COLORECTAL TUMOR-CELLS BY 5-FLUORODEOXYURIDINE - IMPLICATIONS FOR MECHANISMS OF RESISTANCE AND CYTOTOXICITY [J].
CANMAN, CE ;
TANG, HY ;
NORMOLLE, DP ;
LAWRENCE, TS ;
MAYBAUM, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10474-10478
[9]   RESISTANCE TO METHOTREXATE DUE TO GENE AMPLIFICATION IN A PATIENT WITH ACUTE-LEUKEMIA [J].
CARMAN, MD ;
SCHORNAGEL, JH ;
RIVEST, RS ;
SRIMATKANDADA, S ;
PORTLOCK, CS ;
DUFFY, T ;
BERTINO, JR .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (01) :16-20
[10]  
CHENG Y, 1983, MOL PHARMACOL, V23, P171